{
 "as_of": "2026-11-06",
 "cmr": "fr-cm-kg/ALXP/FR0014003XT0",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# NFL BIOSCIENCES S.A. (Euronext Growth Paris: FR0014003XT0) — research page\n\nAs of 2026-11-06 · fr-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is NFL BIOSCIENCES S.A., listed on Euronext Growth Paris under ticker FR0014003XT0, ISIN FR0014003XT0, LEI 9695006VJWNTN4UNHA27. Its security type is Corporate, its sector is NAF 72.19Z, and its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). The segment is not on the record. Status on the record date of 2026-11-06 is listed, not halted.\n\n## The disclosure read\n\nThe record holds 12 filings across 11 filing days in the window 2025-11-06 to 2026-11-06, of which 10 are newswire releases and 2 are results. The median gap between filing days is 25.5 days. The latest filing is dated 2026-10-30, a newswire release, 7 days before the record date. The exchange median is 17.8 days cadence across 258 issuers, with 5.0 median filings and 8 days median latency. The sector median is 8.0 days cadence across 17 issuers, with 17 median filings and 7 days median latency.\n\n## Auditor\n\nThe auditor of record is not on the record, and the auditor's location is not on the record. Auditor changes are not on the record, because the market's register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag is clear: listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names one research house: Invest Securities.\n\n## Open research\n\nThe record holds one openly published research note, by Invest Securities, dated 2021-09-17.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed, so no sealed years hold this issuer, no earliest sealed date is on the record, and the live record start is not on the record.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)\n- https://recherche-entreprises.api.gouv.fr/search?q=494700321 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.fr-cm-kg.ai/events/ALXP/FR0014003XT0 (the disclosure lines)\n- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)\n- https://mcp.fr-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.nflbiosciences.com/en/laction-nfl-biosciences/ (coverage)\n- https://www.nflbiosciences.com/wp-content/uploads/2023/09/20210917-Flash-Invest-ENG.pdf (open research)\n- https://mcp.fr-cm-kg.ai/record/ALXP/FR0014003XT0 (the record)\n",
 "market": "FR",
 "node": "fr-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the FR vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "FR",
    "reason": "Width 0 records the annual report link only (ORDER-016: source link, not a read)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "FR",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "FR",
    "state": "not_on_record"
   },
   "changes": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "fr-cm-kg/ALXP/FR0014003XT0",
  "coverage": {
   "count": 1,
   "houses": [
    {
     "house": "Invest Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.nflbiosciences.com/en/laction-nfl-biosciences/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.nflbiosciences.com/en/laction-nfl-biosciences/",
     "result": "read: 1 of 3 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 258,
     "median_cadence_gap_days": 17.8,
     "median_filings": 5,
     "median_latency_days": 8,
     "name": "Euronext Growth Paris"
    },
    "sector": {
     "issuers": 17,
     "median_cadence_gap_days": 8,
     "median_filings": 17,
     "median_latency_days": 7,
     "name": "NAF 72.19Z"
    }
   },
   "by_type": {
    "newswire_release": 10,
    "results": 2
   },
   "cadence_median_gap_days": 25.5,
   "filing_days": 11,
   "filings": 12,
   "latency_days": 7,
   "latest": [
    {
     "category": null,
     "date": "2026-10-30",
     "source": "https://www.businesswire.com/news/home/20261030237979/en/NFL-Biosciences-will-participate-in-the-BIO-Europe-2026-conference-to-continue-discussions-with-potential-partners-regarding-NFL-101-and-NFL-102",
     "title": "NFL Biosciences will participate in the BIO-Europe 2026 ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-23",
     "source": "https://www.businesswire.com/news/home/20261022686689/en/NFL-Biosciences-Reports-Its-2026-Half-Year-Results-and-Progress-With-Its-Two-Immunotherapies-for-Smoking-and-Nicotine-Cessation",
     "title": "NFL Biosciences Reports Its 2026 Half-Year Results and ...",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-10-22",
     "source": "https://www.businesswire.com/news/home/20261022686689/en/NFL-Biosciences-Reports-Its-2026-Half-Year-Results-and-Progress-With-Its-Two-Immunotherapies-for-Smoking-and-Nicotine-Cessation",
     "title": "NFL Biosciences Reports Its 2026 Half-Year Results and ...",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-10-22",
     "source": "https://www.businesswire.com/news/home/20261021927272/en/NFL-Biosciences-Receives-Regulatory-Approval-to-Begin-Its-Phase-2-TONIC-Trial-for-Smoking-and-Nicotine-Cessation",
     "title": "NFL Biosciences Receives Regulatory Approval to Begin ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-06",
     "source": "https://www.businesswire.com/news/home/20261005969891/en/NFL-Biosciences-Progress-Update-Ahead-of-Upcoming-Value-Creating-Milestones-for-Its-Two-Clinical-Programs-in-Smoking-Cessation",
     "title": "NFL Biosciences: Progress Update Ahead of Upcoming ...",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-10-30",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.fr-cm-kg.ai/events/ALXP/FR0014003XT0",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Euronext Growth Paris"
   },
   "isin": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "confirmed",
    "value": "FR0014003XT0"
   },
   "jurisdiction": {
    "read_by": "French State company search (recherche-entreprises.api.gouv.fr; INSEE / RNE register data) (nature juridique)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://recherche-entreprises.api.gouv.fr/search?q=494700321",
    "state": "sourced",
    "value": "France (RCS-registered SA à conseil d'administration (s.a.i.))"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN FR0014003XT0)",
    "state": "sourced",
    "value": "9695006VJWNTN4UNHA27"
   },
   "name": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "NFL BIOSCIENCES S.A."
   },
   "sector": {
    "read_by": "French State company search (recherche-entreprises.api.gouv.fr; INSEE / RNE register data) (activité principale, NAF)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://recherche-entreprises.api.gouv.fr/search?q=494700321",
    "state": "sourced",
    "value": "NAF 72.19Z"
   },
   "security_type": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "FR",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "FR0014003XT0"
   },
   "website": {
    "market": "FR",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "FR",
  "node": "fr-cm-kg",
  "numbers_hash": "sha256:2dfcbfbfc34b71009de3fd76e1604c5433614a39471d7ac7c0373a2ae756d681",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2021-09-17",
     "kind": "issuer-sponsored",
     "publisher": "Invest Securities",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.nflbiosciences.com/wp-content/uploads/2023/09/20210917-Flash-Invest-ENG.pdf",
     "state": "sourced",
     "title": "NFL BIOSCIENCES"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.fr-cm-kg.ai/book/aio.json",
    "door": "https://mcp.fr-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/fr/mifid-ii-product-governance/r1",
   "section": "fr.aio.v10"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.fr-cm-kg.ai/record/ALXP/FR0014003XT0",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:2dfcbfbfc34b71009de3fd76e1604c5433614a39471d7ac7c0373a2ae756d681",
 "path": "/fr/ALXP/FR0014003XT0",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is NFL BIOSCIENCES S.A., listed on Euronext Growth Paris under ticker FR0014003XT0, ISIN FR0014003XT0, LEI 9695006VJWNTN4UNHA27. Its security type is Corporate, its sector is NAF 72.19Z, and its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). The segment is not on the record. Status on the record date of 2026-11-06 is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 12 filings across 11 filing days in the window 2025-11-06 to 2026-11-06, of which 10 are newswire releases and 2 are results. The median gap between filing days is 25.5 days. The latest filing is dated 2026-10-30, a newswire release, 7 days before the record date. The exchange median is 17.8 days cadence across 258 issuers, with 5.0 median filings and 8 days median latency. The sector median is 8.0 days cadence across 17 issuers, with 17 median filings and 7 days median latency.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and the auditor's location is not on the record. Auditor changes are not on the record, because the market's register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag is clear: listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names one research house: Invest Securities.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds one openly published research note, by Invest Securities, dated 2021-09-17.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed, so no sealed years hold this issuer, no earliest sealed date is on the record, and the live record start is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://recherche-entreprises.api.gouv.fr/search?q=494700321"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.fr-cm-kg.ai/events/ALXP/FR0014003XT0"
  },
  {
   "for": "the halt flag",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.fr-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.nflbiosciences.com/en/laction-nfl-biosciences/"
  },
  {
   "for": "open research",
   "source": "https://www.nflbiosciences.com/wp-content/uploads/2023/09/20210917-Flash-Invest-ENG.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.fr-cm-kg.ai/record/ALXP/FR0014003XT0"
  }
 ],
 "title": "NFL BIOSCIENCES S.A. (FR0014003XT0) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}